These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9884508)

  • 21. Randomized controlled trial of oral itraconazole solution versus intravenous/oral fluconazole for prevention of fungal infections in liver transplant recipients.
    Winston DJ; Busuttil RW
    Transplantation; 2002 Sep; 74(5):688-95. PubMed ID: 12352887
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylaxis and treatment of fungal infections associated with haematological malignancies.
    Ascioglu S; de Pauw BE; Meis JF
    Int J Antimicrob Agents; 2000 Aug; 15(3):159-68. PubMed ID: 10926437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Prophylaxis of fungal infection in patients with hematologic neoplasms and severe neutropenia after high-dose chemotherapy].
    Minenko SV; Zhukov NV; Chimishkian KL; Sokolova EN; Ptushkin VV
    Antibiot Khimioter; 2004; 49(8-9):52-6. PubMed ID: 15727147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical study on the efficacy and safety of intravenous itraconazole infusion for the treatment of invasive fungal infection in china.
    Wang A; Zhang Y; He L; Shen Z; Liao W; Han M; Li R; Liang D; Wu S; Hahn-Ast C; Glasmacher A; Liekwok WA
    Jpn J Infect Dis; 2006 Dec; 59(6):370-6. PubMed ID: 17186955
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oral and intravenous itraconazole for systemic fungal infections in neutropenic haematological patients: meeting report. London, United Kingdom, 20 June 1998.
    Prentice HG; Caillot D; Dupont B; Menichetti F; Schuler U
    Acta Haematol; 1999 Mar; 101(1):56-62. PubMed ID: 10085441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS.
    Caillot D; Bassaris H; McGeer A; Arthur C; Prentice HG; Seifert W; De Beule K
    Clin Infect Dis; 2001 Oct; 33(8):e83-90. PubMed ID: 11550120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Efficacy of intravenous administration of itraconazole on fungal infections in immunocompromised patients with hematological diseases].
    Wang JZ; Huang XJ; Liu KY; Liu DH; Chen H; Xu LP; Lu J; Zhang YC; Han W; Lu DP
    Zhonghua Yi Xue Za Zhi; 2005 Jun; 85(21):1481-3. PubMed ID: 16061027
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antifungal prophylaxis with itraconazole oral solution in neutropenic patients.
    Kibbler CC
    Mycoses; 1999; 42 Suppl 2():121-4. PubMed ID: 10865918
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evidence-based review of antifungal prophylaxis in neutropenic patients with haematological malignancies.
    Glasmacher A; Prentice AG
    J Antimicrob Chemother; 2005 Sep; 56 Suppl 1():i23-i32. PubMed ID: 16120631
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and safety of itraconazole as empirical antifungal therapy in febrile neutropenic patients with hematologic malignancies: an open-lable, multicenter, observational trial in a Chinese cohort.
    Cheng S; Zhou JF; Zou P; Huang XJ; Jin J; Shen ZX
    Chin Med J (Engl); 2011 Nov; 124(22):3670-5. PubMed ID: 22340222
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
    Döring M; Eikemeier M; Cabanillas Stanchi KM; Hartmann U; Ebinger M; Schwarze CP; Schulz A; Handgretinger R; Müller I
    Eur J Clin Microbiol Infect Dis; 2015 Jun; 34(6):1189-200. PubMed ID: 25680318
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The prophylactic effect of itraconazole capsules and fluconazole capsules for systemic fungal infections in patients with acute myeloid leukemia and myelodysplastic syndromes: a Japanese multicenter randomized, controlled study.
    Ito Y; Ohyashiki K; Yoshida I; Takeuchi M; Aoyama Y; Mugitani A; Matsuura Y; Wakita H; Matsuda M; Sakamoto E; Kiguchi T; Urabe A; Tamura K; Kanamaru A; Masaoka T
    Int J Hematol; 2007 Feb; 85(2):121-7. PubMed ID: 17321989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome.
    Mattiuzzi GN; Estey E; Raad I; Giles F; Cortes J; Shen Y; Kontoyiannis D; Koller C; Munsell M; Beran M; Kantarjian H
    Cancer; 2003 Jan; 97(2):450-6. PubMed ID: 12518369
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of intravenous itraconazole as empirical antifungal therapy for persistent fever in neutropenic patients with hematological malignancies in Japan.
    Ohta K; Nishiki Kosaka S; Nakao Y; Kumura T; Hagihara K; Sakamoto E; Okamoto S; Hirose A; Aoyama Y; Yamamura R; Hayashi Y; Umemoto Y; Terada Y; Takeoka Y; Nakane T; Koh H; Hino M
    Int J Hematol; 2009 Jun; 89(5):649-55. PubMed ID: 19449195
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicenter, randomized, open-label study comparing the efficacy and safety of micafungin versus itraconazole for prophylaxis of invasive fungal infections in patients undergoing hematopoietic stem cell transplant.
    Huang X; Chen H; Han M; Zou P; Wu D; Lai Y; Huang H; Chen X; Liu T; Zhu H; Wang J; Hu J
    Biol Blood Marrow Transplant; 2012 Oct; 18(10):1509-16. PubMed ID: 22469884
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Invasive fungal infections in patients with hematological malignancies: a clinical approach].
    García-Ruiz JC; Pontón J
    Med Clin (Barc); 2000 Sep; 115(8):305-12. PubMed ID: 11093887
    [No Abstract]   [Full Text] [Related]  

  • 37. Fungal infection from Fusarium spp. in children with refractory hematologic malignancies.
    Taçyildiz N; Yavuz G; Unal E; Gözdasoğlu S; Ertem M; Aysev D
    Med Pediatr Oncol; 1999 Dec; 33(6):596-7. PubMed ID: 10573590
    [No Abstract]   [Full Text] [Related]  

  • 38. Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients.
    Glasmacher A; Prentice A; Gorschlüter M; Engelhart S; Hahn C; Djulbegovic B; Schmidt-Wolf IG
    J Clin Oncol; 2003 Dec; 21(24):4615-26. PubMed ID: 14673051
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant interferon gamma1b immune enhancement in 20 patients with hematologic malignancies and systemic opportunistic infections treated with donor granulocyte transfusions.
    Safdar A; Rodriguez GH; Lichtiger B; Dickey BF; Kontoyiannis DP; Freireich EJ; Shpall EJ; Raad II; Kantarjian HM; Champlin RE
    Cancer; 2006 Jun; 106(12):2664-71. PubMed ID: 16691620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of intravenous itraconazole followed by oral itraconazole solution in the treatment of invasive pulmonary mycosis.
    Zhang YY; Zhou X;
    Chin Med J (Engl); 2011 Oct; 124(20):3415-9. PubMed ID: 22088546
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.